ENTRY       D06398                      Drug
NAME        Tinzaparin sodium (USAN);
            Innohep (TN)
CLASS       Blood modifier agent
             DG01950  Antithrombotic agent
              DG01709  Heparin anticoagulant
REMARK      ATC code: B01AB10
            Chemical structure group: DG00150
            Product (DG00150): D02112<JP/US> D04427<JP> D03674<JP/US> D04977<JP> D03353<JP/US>
EFFICACY    Anticoagulant, Antithrombin III activator
COMMENT     Low molecular weight heparin (LMWH)
TARGET      SERPINC1 (AT3) [HSA:462] [KO:K03911]
  PATHWAY   hsa04610(462)  Complement and coagulation cascades
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AB Heparin group
                 B01AB10 Tinzaparin
                  D06398  Tinzaparin sodium (USAN)
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01709  Heparin anticoagulant
                DG00150  Heparin
                 D06398  Tinzaparin sodium
            Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Organismal systems
               Complement and coagulation
                SERPINC1 (AT3)
                 D06398  Tinzaparin sodium (USAN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D06398
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D06398
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01709  Heparin anticoagulant
                DG00150  Heparin
DBLINKS     CAS: 9041-08-1
            PubChem: 47208055
            NIKKAJI: J209.198D
///
